1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- Treatments and Mortality Trends in Cases With and Without Dialysis Who Have an Acute Myocardial Infarction : An 18-Year Nationwide Experience
- 2018
- Nya europeiska riktlinjer för behandling av hypertoni - Dags att återigen ta arteriell hypertoni på allvar
- 2017
-
Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but do Not Prevent New-Onset Atrial Fibrillation After Acute Myocardial Infarction
Batra, Gorav ; Lindhagen, Lars ; Andell, Pontus LU ; Erlinge, David LU
;
James, Stefan
;
Spaak, Jonas
and
Oldgren, Jonas
(2017)
In Journal of the American Heart Association
6(3).
Mark
-
Quantitation of 87 Proteins by nLC-MRM/MS in Human Plasma : Workflow for Large-Scale Analysis of Biobank Samples
Rezeli, Melinda LU ; Sjödin, Karin LU ; Lindberg, Henrik LU ; Gidlöf, Olof LU ; Lindahl, Bertil ; Jernberg, Tomas ; Spaak, Jonas ; Erlinge, David LU
and
Marko-Varga, György
LU
(2017)
In Journal of Proteome Research
16(9).
p.3242-3254
Mark
- Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality : A Swedish nationwide observational study
- 2016
- Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal Dysfunction
- 2015
- Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non-ST-segment elevation myocardial infarction.